Pliant Therapeutics (PLRX)

• Market cap: $65.6M
• 1 day: 0.95%
• 5 days: -3.64%
• 1 month: -7.02%
• 3 months: -13.11%
• 6 months: -12.4%
• Year to date: -15.2%
• 1 year: -30.26%
• 5 years: -94.75%
• 10 years: -95.02%
• Sector: Healthcare
• Industry: Biotechnology

About: Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.

Employees: 49